Robotic Stereotactic Ablative Radiotherapy for Patients with Early-Stage Lung Cancer: Results of an Interim Analysis
High LC and OS rates can be achieved with SABR for early-stage lung cancer, with minimal toxicity. This study continues to recruit patients.
Authors
- Zoi Liakouli (ORCID: https://orcid.org/0000-0001-7006-4008)
- Maria Nikoloudi (ORCID: https://orcid.org/0000-0001-6180-7092)
- Ioannis M. Koukourakis (ORCID: https://orcid.org/0000-0003-3143-8585)
- Foteini Simopoulou (ORCID: https://orcid.org/0009-0006-2162-0876)
- Anna Zygogianni
- Christina Armpilia (ORCID: https://orcid.org/0000-0001-7049-6791)
- Ioannis Georgakopoulos (ORCID: https://orcid.org/0000-0002-6354-9805)
- Dimitra Desse (ORCID: https://orcid.org/0000-0002-9074-2395)
- Vassilis Kouloulias (ORCID: https://orcid.org/0000-0003-2082-7323)
- Georgios-Nikiforos Ntoumas (ORCID: https://orcid.org/0000-0002-8770-7142)
Institutions
- National and Kapodistrian University of Athens (GR)
- University General Hospital Attikon (GR)
Publication Details
- Journal
- Cancers
- Published
- 2024-09-22
- DOI
- https://doi.org/10.3390/cancers16183227
- Citations
- 2
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84